TREM2 and Alzheimer disease: In terms of biological risk factors, functional studies have identified AD risk-related genes (e.g., TREM2, CD33) linked to the neuroimmune system (Griciuc and Tanzi, 2021) and proteomic changes implicating an altered metabolome (Johnson et al., 2022).